Malignant Glioma — Trials

Malignant Glioma — Trials · CancerIndex

Clinical trials

Registered studies

2,053 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 589
Recruiting: 314
Ph III recruiting: 16
Growth YoY: +38.9%
Industry share: 18%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (325)

clinicaltrialsPublishedShowing 1–9 of 9 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05023551	Study of DSP-0390 in Patients With Recurrent High-Grade Glioma	active not recruiting	Early Phase 1	39	Sumitomo Pharma America, Inc.INDUSTRY	2	Jul 29, 2026	clinicaltrials
NCT05406700	Niraparib In Recurrent IDH 1/2 Gliomas	active not recruiting	Early Phase 1	16	Massachusetts General HospitalOTHER	1	Jul 24, 2026	clinicaltrials